Lipopolysaccharide from Porphyromonas gingivalis stimulates rat mast cells to cysteinyl leukotriene generation and upregulates toll-like receptor -2 and -4 expression

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 3, 2010, Pages 803-810

  Konopka, L ^a   Wierzbicki, M ^a   Brzezińska Błaszczyk, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Leukotrienes; Mast cells; Porhyromonas gingivalis; Toll like receptors

Indexed keywords

ANTIGEN; HISTAMINE; LAMININ; LIPOPOLYSACCHARIDE; PEPTIDOLEUKOTRIENE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; FEMALE; FLOW CYTOMETRY; HISTAMINE RELEASE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; UPREGULATION;

EID: 78149244099     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300315     Document Type: Article

References (30)

1. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997; 77:1033-79.
2. Galli SJ, Tsai M. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci 2008; 49:7-19.
3. Maurer M, Theoharides T, Granstein RD, et al. What is the physiological function of mast cells? Exp Dermatol 2003; 12:886-910.
4. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 2007; 217:65-78.
5. Dawicki W, Marshall JS. New and emerging roles for mast cells in host defense. Curr Opin Immunol 2007; 19:31-8.
6. Mrabet-Dahbi S, Metz M, Dudeck A, Zuberbier T, Maurer M. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp Dermatol 2009; 18:437-44.
7. Supajatura V, Ushio A, Nakao A, Okumura K, Ra C, Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 2001; 167:2250-6.
8. Wierzbicki M, Brzezińska-Blaszczyk E. Diverse effects of bacterial cell wall components on mast cell degranulation, cysteinyl leukotriene generation and migration. Microbiol Immunol 2009; 53:694-703.
9. Yilmaz Ö. The chronicles of Porphyromonas gingivalis: the microbium, the human oral epithelium and their interplay. Microbiology 2008; 154:2897-903.
10. Hajishengallis G. Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? Microbes Infect 2009; 11:637-45.
11. Gemmell E, Carter CL, Seymour GJ. Mast cells in human periodontal disease. J Dent Res 2004; 83:384-7.
12. Steinsvoll S, Helgeland K, Schenck K. Mast cells - a role in periodontal diseases? J Clin Periodontol 2004; 31:413-9.
13. Walsh LJ. Mast cells and oral inflammation. Crit Rev Oral Biol Med 2003; 14:188-98.
14. Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald WN, Way SS, Hajjar AM. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect Immun 2004; 72:5041-51.
15. Brzezińska-Błaszczyk E, Rdzany RS. Lipoteichoic acids selectively stimulate rat mast cells to cysteinyl leukotriene generation and affect mast cell migration after tumor necrosis factor (TNF)-priming. Immunol Lett 2007; 109:138-44.
16. Pier GB. Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunity. Int J Med Microbiol 2007; 297:277-95.
17. Bryn K, Rietschel ET. L-2-hydroxytetradecanoic acid as a constituent of Salmonella lipopolysaccharide (lipid A). Eur J Biochem 1978; 86:311-5.
18. McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge: Distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003; 170:1625-9.
19. Kikawada E, Bonventre JV, Arm JP. Group V secretory PLA2 regulates TLR2-dependent eicosanoid generation in mouse mast cells through amplification of ERK and cPLA2αactivation. Blood 2007; 110:561-7.
20. Patella V, Casolaro V, Bjorck L, Marone G. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells. J Immunol 1990; 145:3054-61.
21. Genovese A, Bouvet JP, Florio G, Lamparter-Schummert B, Bjorck L, Marone G. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. Infect Immun 2000; 68:5517-24.
22. Peters-Golden M, Henderson WR Jr. Leukotrienes. N Engl J Med 2007; 357:1841-54.
23. Brzezińska-Błaszczyk E, Misiak-Tłoczek A. The regulation of mast cell migration. Part 2: mast cell chemoattractants. Postepy Hig Med Dosw 2007; 61:493-9.
24. Supajatura V, Ushio H, Wada A, Yahiro K, Okumura K, Ogawa H, Hirayama T, Ra C. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 2002; 168:2603-7.
25. Muthukuru M, Jotwani R, Cutler CW. Oral mucosal endotoxin tolerance induction in chronic periodontitis. Infect Immun 2005; 73:687-94.
26. Zhou Q, Amar S. Identification of proteins differentially expressed in human monocytes exposed to Porphyromonas gingivalis and its purified components by high-throughput immunoblotting. Infect Immun 2006; 74:1204-14.
27. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007; 217:204-28.
28. Kinet J-P. The essential role of mast cells in orchestrating inflammation. Immunol Rev 2007; 217:5-7.
29. Stelekati E, Orinska Z, Bulfone-Paus S. Mast cells in allergy: innate instructors of adaptive responses. Immunobiology 2007; 212:509-19.
30. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol 2004; 4:787-99.